Effects of Ingesting Multiple Boluses of Collagen on Muscle & Skin Connective Protein Synthesis in Vivo in Humans
Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · May 24, 2024
Trial Information
Current as of March 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Aged between 18-35 years
- • Male
- • Healthy, recreationally active (participating in recreational sports activities ≥ 1 and ≤ 6 h per week, with a maximum of 2 h resistance-type exercise)
- • 18.5 ≤ BMI ≤ 30 kg/m2
- • No physical limitations (i.e. able to perform all activities associated with daily living in an independent manner).
- Exclusion Criteria:
- • Female
- • Smoking
- • Musculoskeletal disorders
- • Metabolic disorders
- • Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications).
- • Chronic use of gastric acid suppressing medication or anti-coagulants
- • Unstable weight over the last three months
- • Diagnosed GI tract disorders or diseases
- • Blood donation in the past 2 months
Trial Officials
Luc JC van Loon, PhD
Principal Investigator
Maastricht University
About Maastricht University Medical Center
Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maastricht, , Netherlands
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
